The Nanotechnology Knowledge Transfer Network (NanoKTN) is to host this year's Nano4Life conference, which is scheduled to be held in London on 4 February.
Nano4Life 2010, organised by the NanoKTN in collaboration with The Wellcome Trust, will explore the key areas within the life-sciences sector where nanotechnology offers the opportunity to advance healthcare and improve product discovery and development.
The keynote presentation at the event will be delivered by Sir William Castell, chairman of the board of governors at The Wellcome Trust and board director of both GE and BP.
Other presentations will come from Pharmidex Pharmaceutical Services, the NIHR Office for Clinical Research Infrastructure (NOCRI), The Royal Institution and QantuMDX.
Dr Mike Fisher, theme manager at the NanoKTN, said: 'Nanotechnology holds the promise to provide a significant number of healthcare advances and, by hosting the Nano4Life conference, we aim to explore the ways in which the technology can be developed and adopted.
'Nano4Life aims to showcase the latest developments in nanotechnology to the science community and provides an environment to catalyse new collaborations.
'By hosting Nano4Life, the NanoKTN aims to bring together clinicians, academic scientists and industry professionals to drive forward the development of these advances,' he added.
